Report: 3 million people to use smartphone-powered remote care by 2016

iPhone, mobile health - 8.31 Kb
Source: Z. J. Smith, K. Chu, A. R. Espenson, M. Rahimzadeh, A. Gryshuk, M. Molinaro, D. M. Dwyre, S. Lane, D. Matthews, S. Wachsmann-Hogiu.
About three million people are expected to be using smartphone-powered remote patient monitoring devices by 2016, according to a new report from Juniper Research, a wireless analyst firm headquartered in Hampshire, U.K.

The report found that the monitoring of cardiac outpatients is currently leading the field, with the management of diabetes, chronic obstructive pulmonary disease and other chronic diseases to soon play an important role in the remote patient monitoring market.

"Remote patient monitoring will step in to reduce the cost burden of unhealthy lifestyles and aging populations," said report author Anthony Cox. The report called for more trials to prove the benefits of remote patient monitoring.

The report also predicted that:
  • 44 million mobile health applications will be downloaded this year, with an increase to 142 million by 2016;
  • EHRs will become an important component of mobile health offerings;
  • Increased use of smartphones for remote patient monitoring will lower costs by reducing the need for expensive dedicated medical devices; and
  • Further guidance from FDA on the regulation of mobile health apps will spur their use.
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.